Acadia Pharmaceuticals Inc (ACAD)
Equity Ratio
74.97%
Quarterly · Period ending:
ACAD Equity Ratio
Latest reported74.97%period ending
Latest reported74.97%period ending
ACAD Quarterly Equity Ratio (-166.19% → 74.97%)
Latest values, visible window
High-resolution chart · PNG
ACAD equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 74.9675% | |
| 77.75% | |
| 78.4678% | |
| 68.9279% | |
| 67.1028% | |
| 67.5787% | |
| 61.6956% | |
| 59.0847% | |
| 56.5256% | |
| 54.2676% | |
| 57.6476% | |
| 57.2571% | |
| 61.5762% | |
| 57.112% | |
| 68.1192% | |
| 70.6543% | |
| 70.9648% | |
| 71.2529% | |
| 77.2571% | |
| 78.9991% | |
| 77.9701% | |
| 77.0163% | |
| 80.1171% | |
| 82.3045% | |
| 87.2789% | |
| 85.408% | |
| 89.2684% | |
| 90.0342% | |
| 84.3845% | |
| 83.4867% | |
| 88.6852% | |
| 83.8562% | |
| 84.0488% | |
| 86.648% | |
| 87.1989% | |
| 91.2046% | |
| 90.9766% | |
| 90.9567% | |
| 92.3832% | |
| 93.6302% | |
| 93.3295% | |
| 95.4266% | |
| 90.0251% | |
| 92.6732% | |
| 92.8438% | |
| 94.4136% | |
| 95.0934% | |
| 96.7012% | |
| 97.397% | |
| 97.8458% | |
| 96.3055% | |
| 90.7013% | |
| 87.7076% | |
| 77.3305% | |
| 78.2614% | |
| 74.3747% | |
| 58.0964% | |
| 66.3109% | |
| 72.7471% | |
| 76.0197% | |
| 79.4524% | |
| 81.2763% | |
| 77.3246% | |
| -0.4867% | |
| 8.058% | |
| 16.4028% | |
| 24.3841% | |
| 32.4361% | |
| 37.6989% | |
| 76.2065% | |
| 81.9333% | |
| 84.7052% | |
| 84.5171% | |
| 87.0655% | |
| 84.6564% | |
| 87.4537% | |
| 90.0444% | |
| 74.9789% | |
| 75.0011% | |
| 77.6909% | |
| 76.6181% | |
| 62.7523% | |
| 62.9879% | |
| 70.0105% | |
| 83.0491% | |
| 70.4869% | |
| 76.0074% | |
| 78.24% | |
| 80.2795% | |
| -213.0689% | |
| -166.1913% |